BIOCON
|
The Current P/B Ratio of BIOCON is 2.63.
| Share Price | ₹417.1 | Nov 13,2025 |
| Market Cap | ₹55,759.6 Cr | |
| Book Value | ₹21,219.1 Cr | Mar2025 - Consolidated Results |
| Price/Book | 2.63x | Calculated as MarketCap/Book Value |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PB (Price/Book ) ratio of BIOCON
P/B =
Market Capitalization
/ Book Value
or, using per-share numbers:
P/B = Stock Price /
Book Value Per Share
Current Market Cap [ ₹55,759.6 Cr] as on Nov 13,2025
(/) Book Value [ ₹21,219.1 Cr] based on Mar2025 - Consolidated Results
(=) P/B Ratio [ 2.63x ]
Thus, for BIOCON , the investors are currently willing to pay '2.63 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of BIOCON !
The chart below summarizes the trend in P/B Ratio of BIOCON over the last five years.
Historical PB (Price/Book ) ratio chart of BIOCON
PB Ratio Performance Analysis for BIOCON
- BIOCON 's p/b ratio for fiscal years ending Mar2025 to Mar2021 averaged 3.28x.
- BIOCON 's operated at median p/b ratio of 1.93x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, BIOCON 's p/b ratio peaked in Mar2021 at 6.57x.
- BIOCON 's p/b ratio hit its five-year low in Mar2023 of 1.41x.
How does BIOCON 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Book Value | PB Ratio | Market Cap |
|---|---|---|---|
| BIOCON | 21,219.10 | 2.63 | 55,759.6 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 72,218.00 | 5.77 | 416,477.0 |
| DIVIS LABORATORIES LTD | 14,969.00 | 11.69 | 174,934.0 |
| CIPLA LTD | 31,079.30 | 3.97 | 123,250.0 |
| TORRENT PHARMACEUTICALS LTD | 7,590.69 | 17.06 | 129,469.0 |
| DR REDDYS LABORATORIES LTD | 33,404.90 | 3.08 | 103,038.0 |
| MANKIND PHARMA LTD | 14,288.70 | 6.52 | 93,120.4 |
| ZYDUS LIFESCIENCES LTD | 23,953.10 | 3.97 | 95,008.6 |
| LUPIN LTD | 17,119.50 | 5.48 | 93,768.7 |
| AUROBINDO PHARMA LTD | 32,653.30 | 2.15 | 70,210.2 |
| ABBOTT INDIA LTD | 4,204.27 | 14.94 | 62,801.8 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs BIOCON 's P/B Ratio
| Top 10 Industry Peers | PB Ratio |
|---|---|
| Min industry PB | 2.15x |
| Max industry PB | 17.06x |
| Median industry PB | 5.48x |
| Average industry PB | 7.02x |
You may also like the below Video Courses